Prescription drug · ANDA

Cyclophosphamide NDC 10019-938

Cyclophosphamide 500 mg/25mL · Injection, Powder, For solution · Intravenous, Oral · Baxter Healthcare Company

NDC codes

FDA NDC Directory
Product NDC (as listed)10019-938Labeler and product segments. Claims need a package NDC.
Product NDC at billing width10019-0938Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
10019-938-01100190938011 VIAL, SINGLE-DOSE in 1 CARTON (10019-938-01) / 25 mL in 1 VIAL, SINGLE-DOSE (10019-938-25)Marketed from May 21, 2008

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Cyclophosphamide
Generic name (nonproprietary)
cyclophosphamide
Active ingredients
Cyclophosphamide — 500 mg/25mL
Dosage form
Injection, Powder, For solution
Route
Intravenous, Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 040745
Marketing start
Listing expires
Identifiers
Product ID 10019-938_e478e54f-228b-46a1-9347-df729becf777SPL ID e478e54f-228b-46a1-9347-df729becf777SPL set ID 97ab446f-5017-4180-ae65-0a355289b0edRxCUI 1734917, 1734919, 1734921UNII 8N3DW7272P

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N410019093801 followed by a unit qualifier and the quantity

Package 10019-0938-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 040745

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040745
ProductStrengthForm · routeLabelerProduct NDC
CyclophosphamideCyclophosphamide 2 g/100mLInjection, Powder, For solutionIntravenous, OralBaxter Healthcare Company10019-957
CyclophosphamideCyclophosphamide 500 mg/25mLInjection, Powder, For solutionIntravenous, OralBaxter Healthcare Company10019-935
CyclophosphamideCyclophosphamide 1 g/50mLInjection, Powder, For solutionIntravenous, OralBaxter Healthcare Company10019-936
CyclophosphamideCyclophosphamide 2 g/100mLInjection, Powder, For solutionIntravenous, OralBaxter Healthcare Company10019-937
CyclophosphamideCyclophosphamide 500 mg/25mLInjection, Powder, For solutionIntravenous, OralCivica, Inc.72572-087
CyclophosphamideCyclophosphamide 2 g/100mLInjection, Powder, For solutionIntravenous, OralCivica, Inc.72572-083
CyclophosphamideCyclophosphamide 1 g/50mLInjection, Powder, For solutionIntravenous, OralCivica, Inc.72572-085
CyclophosphamideCyclophosphamide 1 g/50mLInjection, Powder, For solutionIntravenous, OralBaxter Healthcare Company10019-939
CyclophosphamideCyclophosphamide 2 g/100mLInjection, Powder, For solutionIntravenous, OralBaxter Healthcare Company10019-942
CyclophosphamideCyclophosphamide 500 mg/25mLInjection, Powder, For solutionIntravenous, OralBaxter Healthcare Company10019-943
CyclophosphamideCyclophosphamide 1 g/50mLInjection, Powder, For solutionIntravenous, OralBaxter Healthcare Company10019-944
CyclophosphamideCyclophosphamide 2 g/100mLInjection, Powder, For solutionIntravenous, OralBamboo US Bidco LCC83703-551
CyclophosphamideCyclophosphamide 2 g/100mLInjection, Powder, For solutionIntravenous, OralBaxter Healthcare Company10019-945
CyclophosphamideCyclophosphamide 500 mg/25mLInjection, Powder, For solutionIntravenous, OralBamboo US Bidco LCC83703-549
CyclophosphamideCyclophosphamide 1 g/50mLInjection, Powder, For solutionIntravenous, OralBamboo US Bidco LCC83703-550
CyclophosphamideCyclophosphamide 500 mg/25mLInjection, Powder, For solutionIntravenous, OralBaxter Healthcare Company10019-955
CyclophosphamideCyclophosphamide 500 mg/25mLInjection, Powder, For solutionIntravenous, OralBluePoint Laboratories68001-442
CyclophosphamideCyclophosphamide 1 g/50mLInjection, Powder, For solutionIntravenous, OralBluePoint Laboratories68001-443
CyclophosphamideCyclophosphamide 2 g/100mLInjection, Powder, For solutionIntravenous, OralBluePoint Laboratories68001-444
CyclophosphamideCyclophosphamide 1 g/50mLInjection, Powder, For solutionIntravenous, OralBaxter Healthcare Company10019-956

Med-Code uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in